Frequency of left ventricular systolic dysfunction in patients receiving Primary Percutaneous intervention vs Delayed Percutaneous intervention presenting with ST- Elevation Myocardial infarction
DOI:
https://doi.org/10.54112/bcsrj.v6i1.1516Keywords:
STEMI, Percutaneous Coronary Intervention, Left Ventricular Dysfunction, Primary PCI, Myocardial Infarction, PakistanAbstract
Left ventricular systolic dysfunction (LVSD) is a significant complication following ST-elevation myocardial infarction (STEMI), associated with an increased risk of heart failure and long-term cardiovascular mortality. Primary percutaneous coronary intervention (PPCI) is the gold-standard treatment for STEMI, yet delayed PCI remains common in Pakistan due to limited healthcare accessibility and delayed patient presentation. This study compares the frequency of LVSD in STEMI patients undergoing PPCI versus delayed PCI at a tertiary care hospital in Lahore, Pakistan. Objective: To evaluate and compare LV systolic function in STEMI patients who underwent early PPCI versus delayed PCI, determining the impact of PCI timing on left ventricular ejection fraction (LVEF) and overall cardiac function. Methods: A prospective observational study was conducted at the Cardiology Department, Punjab Institute of Cardiology Lahore. One hundred sixty patients were enrolled and stratified into PPCI (n=80) and delayed PCI (n=80). Baseline demographics, comorbidities (hypertension, diabetes, dyslipidemia, smoking), and echocardiographic findings (LVEF, LVSD) were recorded. LVSD was defined as LVEF <40% at hospital discharge. Data were analysed using SPSS version 26, with chi-square and independent t-tests for statistical comparisons, considering p ≤ 0.05 statistically significant. Results: The overall prevalence of LVSD was 43.1%, with a significantly higher incidence in delayed PCI patients (57.5%) compared to PPCI patients (28.7%) (p < 0.001). Patients in the PPCI group had significantly higher LVEF at discharge (50.3% ± 7.2) compared to the delayed PCI group (42.1% ± 6.8, p < 0.05). Dyslipidemia (p = 0.001) was significantly associated with LVSD, whereas diabetes mellitus showed a borderline association (p = 0.06). Other risk factors, including hypertension and smoking, were not statistically significant predictors of LVSD. Conclusion: Early PCI significantly reduces the incidence of LV systolic dysfunction in STEMI patients, reinforcing the importance of timely reperfusion therapy to prevent long-term myocardial damage. Delays in PCI were associated with larger infarct size, lower LVEF, and a higher prevalence of LV dysfunction. Given the high burden of STEMI and PCI delays in Pakistan, healthcare policies should prioritise expanding PPCI-capable centres, improving emergency medical services (EMS), and raising awareness of early STEMI symptoms to enhance patient outcomes.
Downloads
References
Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119-177. doi:10.1093/eurheartj/ehx393
Jafar TH, Haaland BA, Rahman A, et al. Non-communicable diseases and injuries in Pakistan: Strategic priorities. Lancet. 2013;381(9885):2281-2290. doi:10.1016/S0140-6736(13)60646-7
O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2013;61(4):e78-e140. doi:10.1016/j.jacc.2012.11.019
Hashmi SK, Alhabib KF, Lopes RD, et al. Patient and system-related delays of STEMI care in South Asia: A systematic review. J Am Coll Cardiol. 2020;75(3):123-132. doi:10.1016/j.jacc.2019.10.037
Bueno H, Rossello X, Pocock SJ, et al. Predictors of sudden cardiac death after myocardial infarction: A global perspective. Eur Heart J. 2019;40(10):883-889. doi:10.1093/eurheartj/ehz318
Mehran R, Baber U, Sartori S, et al. PCI in ST-elevation myocardial infarction: The evolving role of adjunctive therapies. Circ Res. 2018;123(10):1200-1212. doi:10.1161/CIRCRESAHA.118.313269
Silvain J, Abtan J, Cayla G, et al. Impact of time to PCI on myocardial salvage and left ventricular function: Insights from the FAST-MI registry. Eur Heart J. 2018;39(15):1202-1210. doi:10.1093/eurheartj/ehy007
Stone GW, Selker HP, Thiele H, et al. PCI strategies in patients with ST-elevation myocardial infarction. N Engl J Med. 2018;378(12):1111-1121. doi:10.1056/NEJMoa1710324
Reddy NK, Kandala J, Chennapragada S, et al. Impact of delayed primary PCI on left ventricular function in an Indian cohort: A retrospective analysis. Indian Heart J. 2021;73(4):384-389. doi:10.1016/j.ihj.2021.02.001
Shahid G, Farooq S, Khan MU, et al. Delayed reperfusion in STEMI: Insights from a tertiary cardiac center in Pakistan. Pak J Med Sci. 2022;38(5):1208-1213. doi:10.12669/pjms.38.5.4893
Niccoli G, Montone RA, Ferrante G, et al. Coronary microvascular obstruction in acute STEMI: Mechanisms and clinical implications. Eur Heart J. 2016;37(13):1024-1033. doi:10.1093/eurheartj/ehv484
Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the "golden hour." Lancet. 1996;348(9030):771-775. doi:10.1016/S0140-6736(96)02514-7
Garg A, Kim MS, Rha SW, et al. Comparative study of PPCI vs. delayed PCI in STEMI: A real-world perspective from Asia. Circ J. 2021;85(5):812-821. doi:10.1253/circj.CJ-21-0023
Hussain M, Saeed S, Khan M, et al. Clinical outcomes of early vs. delayed PCI in STEMI patients: A Pakistani perspective. J Pak Med Assoc. 2023;73(2):230-236. doi:10.47391/JPMA.23-134
Silvain J, Abtan J, Cayla G, et al. Impact of time to PCI on myocardial salvage and left ventricular function: Insights from the FAST-MI registry. Eur Heart J. 2018;39(15):1202-1210. doi:10.1093/eurheartj/ehy007
Reddy NK, Kandala J, Chennapragada S, et al. Impact of delayed primary PCI on left ventricular function in an Indian cohort: A retrospective analysis. Indian Heart J. 2021;73(4):384-389. doi:10.1016/j.ihj.2021.02.001
Stone GW, Selker HP, Thiele H, et al. PCI strategies in patients with ST-elevation myocardial infarction. N Engl J Med. 2018;378(12):1111-1121. doi:10.1056/NEJMoa1710324
Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the "golden hour." Lancet. 1996;348(9030):771-775. doi:10.1016/S0140-6736(96)02514-7
Mehran R, Baber U, Sartori S, et al. PCI in ST-elevation myocardial infarction: The evolving role of adjunctive therapies. Circ Res. 2018;123(10):1200-1212. doi:10.1161/CIRCRESAHA.118.313269
Niccoli G, Montone RA, Ferrante G, et al. Coronary microvascular obstruction in acute STEMI: Mechanisms and clinical implications. Eur Heart J. 2016;37(13):1024-1033. doi:10.1093/eurheartj/ehv484
Hussain M, Saeed S, Khan M, et al. Clinical outcomes of early vs. delayed PCI in STEMI patients: A Pakistani perspective. J Pak Med Assoc. 2023;73(2):230-236. doi:10.47391/JPMA.23-134
Garg A, Kim MS, Rha SW, et al. Comparative study of PPCI vs. delayed PCI in STEMI: A real-world perspective from Asia. Circ J. 2021;85(5):812-821. doi:10.1253/circa.CJ-21-0023
Shahid G, Farooq S, Khan MU, et al. Delayed reperfusion in STEMI: Insights from a tertiary cardiac centre in Pakistan. Pak J Med Sci. 2022;38(5):1208-1213. doi:10.12669/pjms.38.5.4893
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Muhammad Hannan Yousuf, Uzma Majeed, Rida Basharat, Shahzaib Shahzad, Muhammad Arsalaan Awais, Hafiz Mudabbar Mahboob

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.